Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1893 studies found for:    Open Studies | "Diabetes Mellitus"
Show Display Options
Rank Status Study
1 Recruiting ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus
Condition: Diabetes Mellitus Type 2
Intervention: Behavioral: Shared Decision Making
2 Not yet recruiting Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Evogliptin;   Drug: Sitagliptin;   Drug: Placebo Evogliptin;   Drug: Placebo Sitagliptin
3 Recruiting Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Intervention: Other: BMMCT
4 Recruiting An Exploratory Study to Evaluate the Effects of Trelagliptin and Alogliptin by CGM on Glucose Variability for One Week With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Trelagliptin;   Drug: Alogliptin
5 Recruiting Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus
Condition: Type I Diabetes Mellitus
Interventions: Drug: Subetta;   Drug: Placebo
6 Recruiting Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
Condition: Type II Diabetes Mellitus
Interventions: Drug: Subetta;   Drug: Placebo
7 Not yet recruiting Use of Stem Cells in Diabetes Mellitus Type 1
Condition: Diabetes Mellitus Type 1
Intervention: Biological: Adipose mesenchymal cells with bone marrow mononuclear cells
8 Recruiting Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Albiglutide weekly injection;   Biological: Placebo weekly injection;   Biological: Insulin
9 Recruiting Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
Condition: Diabetes Mellitus Type II
Interventions: Drug: Liraglutide;   Drug: Insulin bolus;   Drug: GIK infusion
10 Recruiting Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes Mellitus
Condition: Non-Insulin Dependent Diabetes Mellitus
Intervention:
11 Recruiting A Study of Single and Multiple Doses of ORMD-0801 (Study Drug) or Placebo in Subjects With T2 (Type 2) DM (Diabetes Mellitus)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: ORMD-0801 (qd);   Drug: ORMD-0801 (bid);   Drug: ORMD-0801 (tid);   Other: Placebo
12 Not yet recruiting Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Lixisenatide;   Drug: Basal insulins
13 Recruiting Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Biological: Albiglutide 30 mg;   Biological: Albiglutide 50 mg;   Biological: Albiglutide matching placebo
14 Recruiting Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: DbXell;   Dietary Supplement: Placebo
15 Recruiting A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: ASP1941;   Drug: Placebo;   Other: Insulin Therapy
16 Recruiting An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada
Condition: Diabetes Mellitus, Type 2
Intervention: Other: No Intervention
17 Recruiting Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes
Condition: Diabetes Mellitus
Intervention: Other: PATH electronic decision support tool
18 Recruiting Balance After Baby Intervention for Women With Recent Gestational Diabetes
Condition: Gestational Diabetes Mellitus
Intervention: Behavioral: BABI-2 Lifestyle Intervention
19 Recruiting Exploratory Study on Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: INGAP Peptide, Ustekinumab
20 Recruiting A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ipragliflozin L-proline;   Drug: Metformin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.